Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs propofol sedation with remifentanil in mechanically ventilated EICU patients
ChiCTR2500099897Phase 4Not yet recruiting
- Sponsor
- Huzhou Central Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (2 arms), sponsored by Huzhou Central Hospital. Primary endpoint: Duration of mechanical ventilation. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500099897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099897.